ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1117

Integrated 18f-Fluoride Positron Emission Tomography and Magnetic Resonance Imaging Of The Spine – a Pilot Study and Comparison Of Signals In Patients With Axial Spondyloarthritis

Xenofon Baraliakos1, Dr. Christian Buchbender2, Ben Ostendorf3, Verena Hartung, MD4, Thorsten Poeppel, MD4 and Juergen Braun5, 1Rheumatology, Rheumazentrum Ruhrgebiet, Herne, Germany, 2Department of Diagnostic and Interventional Radiology, Univ. Duesseldorf, Düsseldorf, Germany, 3Rheumatology, Heinrich-Heine-University, Duesseldorf, GA, Germany, 4Dept. Nuclear Medicine, University Duisburg-Essen, Duisburg, Germany, 5Rheumazentrum Ruhrgebiet, Herne, Germany

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Ankylosing spondylitis (AS), magnetic resonance imaging (MRI) and positron emission tomography (PET)

  • Tweet
  • Email
  • Print
Session Information

Title: Imaging of Rheumatic Diseases II: Imaging in Spondyloarthritis and Osteoarthritis

Session Type: Abstract Submissions (ACR)

Background/Purpose:   Positron emission tomography (PET) is a high sensitive nuclear imaging technique that depicts functional processes within the body. PET scanners detect annihilation radiation from radioactive decay of a positron-emitting radionuclide labeled to a biologically active molecule (tracer) and introduced into the body. User-defined cross-sectional images of the tracer distribution can then be reconstructed from the acquired 3D data set. 18F-fluoride (18F) can be used for PET as a bone-seeking agent reflecting bone perfusion and remodeling. The concentration of the tracer then represents the metabolic activity and regional bone remodeling. Recently, an integrated PET/MR device was introduced with the ability to provide simultaneously acquired images that combine morphological and metabolic information. Based on our long experience with MRIs of patients with axial spondyloarthritis (axSpA) we inaugurated a pilot study with simultaneous PET/MR in order to examine whether the addition of the PET technique may provide different and additional information in comparison to MRI alone.

Methods: Eleven axSpA patients, median age 39 years, disease duration range 0.5-10 years, mean BASDAI 5.3, most of them fulfilling the NY criteria for AS, were examined by PET/3-Tesla MRI 40 minutes after injection of a mean dose of 157 MBq of 18F using a integrated whole-body PET/MR scanner (Siemens Biograph mMR®). 3T-MRIs were scored blinded to patient´s clinical characteristics by two readers (1 rheumatologist and 1 radiologist/nuclear medicine specialist) using the Berlin MRI score and also by recording inflammatory lesions on a vertebral edge (VE) level. In a second step PET/MRIs were read blindly by the same readers also based on the VE involvement of individual vertebral bodies.

Results: Acquisition of whole-spine integrated 18F PET/MRI scans was successful in all patients. The resulting mean effective radiation dose per patient was 3.76 mSv. Co-registration of PET/MRI fusion images was highly accurate and allowed a precise comparison of MRI and PET findings. The mean Berlin MRI score was 6.8 (range 0 – 31). In the direct comparison of the MRI and PET signal the two readers saw consistent signals in almost 90% of the sites studied. However, there were some areas where signals differed, for example within existing syndesmophytes where the PET signal was increased but conventional MRIs showed no signal of active inflammation, or the area of sternum and lateral or posterior spinal elements such as facet joints and spinous process.

Conclusion: The new technique of integrated PET/MRI provides largely similar imaging signals as conventional MRI. However, we did observe differences between the two modalities – especially in areas with less inflammatory activity where bone metabolism seemed to be active or in areas with blurred resolution on conventional MRI. More studies are needed to answer the question whether the differences between these techniques are pathogenically relevant, whether they can be reliably reproduced and quantified, and, of course, whether they are sensitive to change. Especially the possibility that PET detects osteoblastic activity in areas where no inflammatory signal is detected with MRI seems to be of interest.


Disclosure:

X. Baraliakos,
None;

D. C. Buchbender,
None;

B. Ostendorf,
None;

V. Hartung, MD,
None;

T. Poeppel, MD,
None;

J. Braun,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/integrated-18f-fluoride-positron-emission-tomography-and-magnetic-resonance-imaging-of-the-spine-a-pilot-study-and-comparison-of-signals-in-patients-with-axial-spondyloarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology